Search

everythinglearnresearchcommunity

for

Search:↓

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Rosa rugosa extract promotes hair growth and could be a natural treatment for hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Spironolactone was effective in reducing hair growth in women with hirsutism.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Both estrogens and androgens are important for health in both males and females.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.